Avenue Biosciences raises $5.7M to scale the first platform modulating the secretory pathway for enhanced therapeutic protein manufacturing
[image] · Funding will be used to scale the first technology for measuring and modulating the efficacy of the protein secretory pathway, a critical bottleneck